首页> 美国卫生研究院文献>Molecules >Bioactive Abietane-Type Diterpenoid Glycosides from Leaves of Clerodendrum infortunatum (Lamiaceae)
【2h】

Bioactive Abietane-Type Diterpenoid Glycosides from Leaves of Clerodendrum infortunatum (Lamiaceae)

机译:来自Clerodendrum Infortunatum叶子的生物活性腺类型二萜甙(LamiCeae)

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In this study, two previously undescribed diterpenoids, (5R,10S,16R)-11,16,19-trihydroxy-12-O-β-d-glucopyranosyl-(1→2)-β-d-glucopyranosyl-17(15→16),18(4→3)-diabeo-3,8,11,13-abietatetraene-7-one (1) and (5R,10S,16R)-11,16-dihydroxy-12-O-β-d-glucopyranosyl-(1→2)-β-d-glucopyranosyl-17(15→16),18(4→3)-diabeo-4-carboxy-3,8,11,13-abietatetraene-7-one (2), and one known compound, the C13-nor-isoprenoid glycoside byzantionoside B (3), were isolated from the leaves of Clerodendrum infortunatum L. (Lamiaceae). Structures were established based on spectroscopic and spectrometric data and by comparison with literature data. The three terpenoids, along with five phenylpropanoids: 6′-O-caffeoyl-12-glucopyranosyloxyjasmonic acid (4), jionoside C (5), jionoside D (6), brachynoside (7), and incanoside C (8), previously isolated from the same source, were tested for their in vitro antidiabetic (α-amylase and α-glucosidase), anticancer (Hs578T and MDA-MB-231), and anticholinesterase activities. In an in vitro test against carbohydrate digestion enzymes, compound 6 showed the most potent effect against mammalian α-amylase (IC50 3.4 ± 0.2 μM) compared to the reference standard acarbose (IC50 5.9 ± 0.1 μM). As yeast α-glucosidase inhibitors, compounds 1, 2, 5, and 6 displayed moderate inhibitory activities, ranging from 24.6 to 96.0 μM, compared to acarbose (IC50 665 ± 42 μM). All of the tested compounds demonstrated negligible anticholinesterase effects. In an anticancer test, compounds 3 and 5 exhibited moderate antiproliferative properties with IC50 of 94.7 ± 1.3 and 85.3 ± 2.4 μM, respectively, against Hs578T cell, while the rest of the compounds did not show significant activity (IC50 > 100 μM).
机译:在这项研究中,两个先前未描述的二萜类化合物,(5R,10S,16R)-11,16,19 - 三羟基 - 12-O-β-d吡喃葡萄糖基 - (1→2)-β-d-D-吡喃葡萄糖基 - 17(15 →16),18(4→3)-diabeo-3,8,11,13-abietatetraene -7-酮(1)和(5R,10S,16R)-11,16二羟基-12-O-β- d吡喃葡萄糖基 - (1→2)-β-d-D-吡喃葡萄糖基 - 17(15→16),18(4→3)-diabeo -4-羧基3,8,11,13-abietatetraene -7-酮( 2),和一种已知的化合物,所述C13去甲类异戊二烯糖苷byzantionoside B(3),从臭infortunatum L.(唇形科)的叶子中分离。结构是基于光谱和光谱数据,并与文献数据进行比较确定。三个萜类化合物,具有五个沿苯丙:6'--O-咖啡酰-12- glucopyranosyloxyjasmonic酸(4),jionoside C(5),jionoside d(6),brachynoside(7),和incanoside C(8),先前分离的从相同的源,测试它们在体外抗糖尿病(α淀粉酶和α葡糖苷酶),抗癌(HS578T和MDA-MB-231),和抗胆碱酯酶活性测试。在对碳水化合物的消化酶的体外试验中,化合物6显示针对哺乳动物α淀粉酶相比的参考标准阿卡波糖(IC 50 5.9±0.1μM)的最有效的效果(IC 50 3.4±0.2微米)。酵母α葡萄糖苷酶抑制剂,化合物1,2,图5和6显示中等抑制活性,从24.6至96.0微米,相比于阿卡波糖(IC 50 665±42μM)。所有测试的化合物表现出的可忽略的抗胆碱酯酶作用。在抗癌试验,化合物分别与94.7±1.3和85.3±2.4μM的IC 50,图3个5显示出适度的抗增殖特性,针对HS578T细胞,而所述化合物的其余部分没有显示出显著活性(IC 50>100μM)。

著录项

相似文献

  • 外文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号